Cargando…
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity
Inhibitory myeloid cells and their cytokines play critical roles in limiting chimeric antigen receptor T (CART) cell therapy by contributing to the development of toxicities and resistance following infusion. We have previously shown that neutralization of granulocyte-macrophage colony-stimulating f...
Autores principales: | Cox, Michelle J., Roman, Claudia Manriquez, Tapper, Erin E., Siegler, Elizabeth L., Chappell, Dale, Durrant, Cameron, Ahmed, Omar, Sinha, Sutapa, Mwangi, Raphael, Scott, Nancy S., Hefazi, Mehrdad, Schick, Kendall J., Horvei, Paulina, Ruff, Michael W., Can, Ismail, Adada, Mohamad, Bezerra, Evandro, Fonkoua, Lionel Aurelien Kankeu, Parikh, Sameer A., Kay, Neil E., Sakemura, Reona, Kenderian, Saad S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234947/ https://www.ncbi.nlm.nih.gov/pubmed/35440691 http://dx.doi.org/10.1038/s41375-022-01572-7 |
Ejemplares similares
-
In vivo CART cell imaging: Paving the way for success in CART cell therapy
por: Sakemura, Reona, et al.
Publicado: (2021) -
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
por: Kankeu Fonkoua, Lionel A., et al.
Publicado: (2022) -
CART Cell Toxicities: New Insight into Mechanisms and Management
por: Zahid, Anas, et al.
Publicado: (2020) -
P1359: TUMOR-SPECIFIC, T-CELL-TARGETING MICRORNA IS ASSOCIATED WITH CART CELL FAILURE IN B CELL MALIGNANCIES
por: Chohan, Karan, et al.
Publicado: (2023) -
Characterization of the Two CART Genes (CART1 and CART2) in Chickens (Gallus gallus)
por: Cai, Guoqing, et al.
Publicado: (2015)